QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Anixa Biosciences (ANIX) SEC Filings & 10K Form

$3.12
+0.02 (+0.65%)
(As of 04:37 PM ET)

Recent Anixa Biosciences SEC Filings

DateFilerForm TypeView
04/10/2024
8:44 AM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Titterton Lewis H jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
3:30 PM
Anixa Biosciences Inc (Filer)
Anixa Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
1:15 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Baskies Arnold M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
9:49 AM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
KUMAR AMIT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:15 PM
Anixa Biosciences Inc (Filer)
Anixa Biosciences (Filer)
Form DEF 14A
01/16/2024
6:05 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Titterton Lewis H jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:05 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
KUMAR AMIT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:07 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Catelani Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:07 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Gottschalk Emily (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
6:08 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Baskies Arnold M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:29 PM
Anixa Biosciences Inc (Subject)
Anixa Biosciences (Subject)
KUMAR AMIT (Filed by)
Form SC 13D/A
01/16/2024
3:43 PM
Anixa Biosciences Inc (Filer)
Anixa Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/16/2024
3:30 PM
Anixa Biosciences Inc (Filer)
Anixa Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/07/2023
5:01 AM
Anixa Biosciences Inc (Filer)
Anixa Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
9:58 AM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Catelani Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
9:35 AM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Titterton Lewis H jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
3:15 PM
Anixa Biosciences Inc (Filer)
Anixa Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2023
5:34 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
KUMAR AMIT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2023
5:36 PM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Titterton Lewis H jr (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
9:06 AM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Catelani Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
4:09 PM
Anixa Biosciences Inc (Filer)
Anixa Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2023
9:45 AM
Anixa Biosciences Inc (Issuer)
Anixa Biosciences (Issuer)
Catelani Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ANIX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners